The implementation gap lies somewhere between management classes and engineering and science classes. Recognizing the need for managers in science-based businesses to understand technology development and for engineers and scientists to understand business issues as they guide and make decisions on the science, Shreefal Mehta conceptualized and co-taught the course “Commercializing Biomedical Technologies” at RPI, along with colleague Dr Jan Stegemann. A follow-on course was also created – “From Idea to Execution: Building, Managing and Growing a Science-Based Business”.
Shreefal Mehta also formulated the experiential portion of the now widely renowned leading European week-long immersive BioBusiness course in Lugano, Switzerland for young biotech CEOs and executives.
Shreefal has consulted on technology commercialization planning and market planning for new breakthrough technologies. He also assists companies in planning business development activities, company building, and integration in international business mergers and acquisitions.
Shreefal has been an invited speaker at several international conferences in the US, Australia and Asia, speaking on topics covering biotechnology entrepreneurship, radical innovation management, technology transfer and international and intra-firm business models.
As biotechnology initiatives around the world build momentum, it is critical to increase awareness of these opportunities and challenges at Rensselaer and throughout the region. The Biotechnology Management & Entrepreneurship Seminar Series at the Lally School at Rensselaer brought awareness of the opportunities and challenges in Tech Valley’s emerging biotech R&D hub, while providing an excellent forum for exchange and local networking for all participating sites. It was also the springboard for the successful Capital Region BioConnex initiative.
The Biotechnology Management & Entrepreneurship Seminar Series brought in world-renowned speakers to address issues of growing companies in an intensively science-based business like biotechnology. Since 2001, over 40 world-renowned leading executives, venture capitalists, entrepreneurs, scientists and Wall Street analysts from multinational companies, small start-ups and dynamic emerging biotechnology companies have covered diverse topics in management, and entrepreneurship of biotechnology business.
The Seminar Series served the local and regional biotechnology commercialization community, with a live network of video-conference locations throughout upstate NY in Cornell University (Ithaca, NY), CNYMedTech (Syracuse, NY), State University of Buffalo (Life Sciences CAT, Buffalo NY) and Rochester Medical Center (Rochester, NY). The archived presentations are available as slides (2001-2004) and webstreaming video (2004-2007). The list of past speakers can be found here.